Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 2802-2810 |
Journal | Clinical Cancer Research |
Volume | 21 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2015 |
Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib
I.S. Nijhof, R.W.J. Groen, W.A. Noort, B. van Kessel, R. de Jong-Korlaar, J. Bakker, J.J.L. van Bueren, P.W.H.I. Parren, H.M. Lokhorst, N.W.C.J. van de Donk, A.C.M. Martens, T. Mutis
Research output: Contribution to journal › Article › Academic › peer-review
128
Citations
(Scopus)